Results 251 to 260 of about 111,447 (309)

Safety of Antihypertensive Medication for the Management of Non‐Severe Gestational Hypertension Among Pregnant Individuals in Botswana—Emulating a Series of Target Trials

Paediatric and Perinatal Epidemiology, EarlyView.
ABSTRACT Background Data on antihypertensive medication for non‐severe gestational hypertension may suffer from immortal time and selection bias. Emulating target trials can prevent these biases by aligning follow‐up with treatment initiation. Objectives We estimated the safety of antihypertensive medication initiation for the treatment of non‐severe ...
Julia D. DiTosto, Rebecca Zash, Denise L. Jacobson, Katherine Johnson, Modiegi Diseko, Gloria Mayondi, Judith Mabuta, Mompati Mmalane, Joseph Makhema, Sunni L. Mumford, Shahin Lockman, Roger Shapiro, Ellen C. Caniglia   +12 more
wiley   +1 more source

Anionic lipopeptides from Bacillus mojavensis I4 as effective antihypertensive agents: Production, characterization, and identification. [PDF]

Eng Life Sci, 2017
Ghazala I, Bouassida M, Krichen F, Manuel Benito J, Ellouz-Chaabouni S, Haddar A.   +5 more
europepmc   +1 more source

Impact of Mental Disorders on the Association Between Adherence to Antihypertensive Agents and All-Cause Healthcare Costs. [PDF]

J Clin Hypertens (Greenwich), 2017
Gentil L, Vasiliadis HM, Préville M, Berbiche D.   +3 more
europepmc   +1 more source

How to treat arterial stiffness beyond blood pressure lowering? [PDF]

, 2011
De Backer, Tine, De Buyzere, Marc, Van Bortel, Lucas   +2 more
core   +1 more source

The Association Between Use of Inhaled Corticosteroids and Long‐Acting Beta2‐Agonists During Pregnancy and Adverse Fetal Outcomes

Respirology, EarlyView.
This study updated safety evidence on ICS and LABA use in pregnant women with asthma. After adjusting confounders, there was no association between ICS or LABA use and adverse fetal outcomes. However, high‐dose ICS exposure was associated with a higher risk of congenital anomalies among ICS users.
Yea‐Chwen Wu, I‐Te Wang, Hsin‐Yi Huang, Chung‐Hsuen Wu   +3 more
wiley   +1 more source

Antihypertensive agents acting on the renin-angiotensin system and the risk of sepsis. [PDF]

Br J Clin Pharmacol, 2014
Dial S, Nessim SJ, Kezouh A, Benisty J, Suissa S.   +4 more
europepmc   +1 more source

Clinical pharmacology of antihypertensive agents. Future view of antihypertensive agents. New antihypertensive agents.

, 1997
Satoshi Umemura
openalex   +2 more sources

Sodium–glucose cotransporter 2 inhibitors for hypertension in cardiovascular–kidney–metabolic syndrome

Experimental Physiology, EarlyView.
Abstract The antihypertensive mechanism of sodium–glucose cotransporter 2 (SGLT2) inhibitors has been traditionally attributed to osmotic diuresis. However, emerging evidence reveals multifaceted mechanisms beyond diuresis, including regulation of the renin–angiotensin–aldosterone system, sympathetic nervous system suppression, ion homeostasis ...
Chunxiang Xu, Xingyu Qiu, Nan Xu, Gensheng Zhang, Enyin Lai, Liang Zhao   +5 more
wiley   +1 more source

Prevention of fostamatinib-induced blood pressure elevation by antihypertensive agents. [PDF]

Pharmacol Res Perspect, 2015
Lengel D, Lamm Bergström E, Barthlow H, Oldman K, Musgrove H, Harmer A, Valentin JP, Duffy P, Braddock M, Curwen J.   +9 more
europepmc   +1 more source

Differential Effects of Antihypertensive Agents on Proliferation of Vascular Smooth Muscle Cells from Spontaneously hypertensive Rats.

, 1991
Satoru Kuriyama, Koji Nakamura, Yoshihiko Kaguchi, Haruo Tomonari, Goro Tokutome, Takao Hashimoto, Osamu Sakai   +6 more
openalex   +2 more sources